Bill Hatfield joined Karyopharm in May 2015 as Senior Vice President of Commercial Development, bringing with him over 30 years of experience in Oncology, Marketing, Commercial Strategy and Product Development in both the pharmaceutical and biotechnology industries in domestic and international markets. He has helped develop the commercial oncology teams at several prominent pharmaceutical companies.
Prior to joining Karyopharm, Bill was the Vice President, New Product Strategy at Sanofi Oncology. Additionally Bill held senior level positions in Marketing, Sales and Business Development at Genzyme and at Millennium Pharmaceuticals, where he was instrumental in the US commercial launch of Velcade.
Bill graduated Magma Cum Laude from the Boston University, School of Management. He holds a BS in Business Administration with a concentration in Marketing.